학술논문
Targeting Sumoylation with Subasumstat (TAK-981), a Selective Inhibitor of SUMO-Activating Enzyme (SAE), Induces Mitochondrial Dysfunction in Preclinical Models of Non-Hodgkin Lymphoma (NHL)
Document Type
Abstract
Author
Source
In Blood 15 November 2022 140 Supplement 1:6016-6017
Subject
Language
ISSN
0006-4971